Global Health Nutrition Grant Received By Harvard University The Harvard Initiative for Global
Health (HIGH) has been selected to receive a prestigious $400,000 Framework Programs for Global
Health grant from the National Institutes of
Health's Fogarty International Center. The three year award will be supplemented by an additional $300,000 grant from the University and support HIGH's development of a curriculum in nutrition and global heath.
Source: www.medicalnewstoday.comFDA Expands Use Of HPV Vaccine Gardasil For Vaginal, Vulvar Cancer Prevention FDA on Friday approved expanding the use of Merck's human papillomavirus vaccine Gardasil to protect against cancers of the vagina and vulva, the AP/MSNBC.com reports (AP/MSNBC.com, 9/12). According to an FDA
Source: www.medicalnewstoday.comFederal Court Panel Grants Appeal For Woman Denied Asylum For Seeking To Avoid Forced Sterilization In China A three-judge panel of the 11th Circuit Court of Appeals in Atlanta on Thursday ruled that a Chinese woman who feared sterilization under China's family planning law can challenge her denial of asylum in the U.S. under the Convention Against Torture, the AP/Macon Telegraph reports.
Source: www.medicalnewstoday.comInvestigational Drug Shows Promise In Ovarian Cancer An investigational drug that combats ovarian cancer by inhibiting the formation of new blood vessels has shown promise in a phase II trial, according to a presentation at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm. Prof. Michael Friedlander from Australia presented the results of an international collaborative trial which administered the drug to 35 patients with recurrent ovarian, fallopian tube or peritoneal carcinoma.
Source: www.medicalnewstoday.comPromising New Treatment Option For Women With Recurrent Ovarian Cancer Combining the new drug trabectedin with pegylated liposomal doxorubicin provides clinical benefit to women with relapsed ovarian cancer, according to new results presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm. The combination, which importantly does not include a platinum drug, challenges the current standard of treatment for women whose cancer recurs at least 6 months after first-line treatment, said Associate Prof. Bradley J.
Source: www.medicalnewstoday.comMcCain Campaign Releases New Ad Touting His Support For Stem Cell Research Republican presidential nominee Sen. John McCain (Ariz.) on Friday released a radio advertisement that states his support for stem cell research, The Hill reports. According to The Hill, the ad does not mention specifically human embryonic stem cell research.
Source: www.medicalnewstoday.comStudy Of Yondelis(R) In Ovarian Cancer Shows Significant Prolongation In Progression Free Survival Positive final results of the Phase III randomized pivotal study of Yondelis® in ovarian cancer were presented during the Presidential Symposium at the ESMO congress in Stockholm. ESMO selects clinical studies that may result in a change in the current standard of care for presentation at the 2008 Presidential Symposium. In total, 672 patients in 124 hospitals across 21 countries worldwide were enrolled in the pivotal study OVA-301, initiated in 2005.
Source: www.medicalnewstoday.com52 Percent Of Newly Diagnosed Bipolar Disorder Patients Receive Antidepressant Drugs In First-Line Treatment Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and
healthcare issues, finds that 52.3 percent of newly diagnosed bipolar disorder patients are prescribed antidepressant
drugs first line. The new report entitled Treatment Algorithms in Bipolar Disorder finds that this high preponderance of early-line antidepressant use stems from primary care physician prescribing.
Source: www.medicalnewstoday.comGlobal Study Shows That Majority Of Women With Osteoporosis Do Not Consider Themselves At Higher Risk For Fractures Results from the Global Longitudinal study of Osteoporosis in Women (GLOW) showed that 55 percent of women diagnosed with osteoporosis do not believe they are at a higher risk of fractures than their peers. This latest study from GLOW included more than 60,000 women over age 55 and was presented at the American Society for Bone and Mineral Research (ASBMR) 30th Annual Meeting.
Source: www.medicalnewstoday.comNew Research In WHO Report Points To A Link Between Solid Employment And Health Despite low overall unemployment, Canada's manufacturing industry has cut 88,000 jobs this year, with nearly all the losses occurring in Ontario. Also, part-time employment has grown by 3.5 per cent in 12 months, much faster than the 0.9 per cent growth in full time work. A new report from the World
Health Organization (WHO) on the social determinants of
health demonstrates that these kind of employment changes can affect more than your wallet.
Source: www.medicalnewstoday.com
# posted by Network @ 11:00 AM
